Alkem Laboratories Limited (NSE:ALKEM)
5,702.00
+60.00 (1.06%)
Apr 21, 2026, 3:29 PM IST
Alkem Laboratories Revenue
Alkem Laboratories had revenue of 37.37B INR in the quarter ending December 31, 2025, with 10.74% growth. This brings the company's revenue in the last twelve months to 142.53B, up 11.73% year-over-year. In the fiscal year ending March 31, 2025, Alkem Laboratories had annual revenue of 129.65B with 2.34% growth.
Revenue (ttm)
142.53B
Revenue Growth
+11.73%
P/S Ratio
4.73
Revenue / Employee
7.59M
Employees
18,785
Market Cap
674.59B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 129.65B | 2.97B | 2.34% |
| Mar 31, 2024 | 126.68B | 10.68B | 9.21% |
| Mar 31, 2023 | 115.99B | 9.65B | 9.08% |
| Mar 31, 2022 | 106.34B | 17.69B | 19.96% |
| Mar 31, 2021 | 88.65B | 5.21B | 6.24% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aurobindo Pharma | 331.82B |
| Cipla | 279.67B |
| Zydus Lifesciences | 260.89B |
| Glenmark Pharmaceuticals | 165.10B |
| Mankind Pharma | 139.14B |
| Divi's Laboratories | 103.14B |
| Ipca Laboratories | 95.06B |
| Emcure Pharmaceuticals | 88.50B |
Alkem Laboratories News
- 8 days ago - Alkem Laboratories sets up Dubai free zone subsidiary to drive pharma exports to Africa and South East Asia - Business Upturn
- 8 days ago - Alkem Laboratories establishes wholly owned subsidiary in Dubai - Business Upturn
- 14 days ago - Alkem launches A to Z Daily multivitamin with 26 essential nutrients - Business Upturn
- 19 days ago - Alkem Laboratories increases investment to Rs 1,036 crore for Ujjain facility - Business Upturn
- 22 days ago - Alkem Laboratories establishes wholly owned subsidiary in UAE - Business Upturn
- 4 weeks ago - Alkem Laboratories launches semaglutide injection in India at Rs 450 weekly therapy cost - Business Upturn
- 4 weeks ago - Alkem Laboratories receives EU GMP certificate for Daman facility - Business Upturn
- 4 weeks ago - Alkem Laboratories to invest ₹533 crore in new Ujjain manufacturing facility - Business Upturn